CELC
Celcuity Inc. Health Care Services-Medical Laboratories Russell 3000
$69.13Close
$3.3BMarket cap
$56.58 – $144.9852-week range
Nov 5, 2026Next report · after the close
Highlights
Cautions
- Not in an uptrend 0 of 8 trend conditions
- Lagging the market RS 11 · weaker than 89% of stocks over 12 months
- Far from its high 52% below its 52-week high
- Results soon Nov 5, 2026, in 4 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
52%
1wk
up 5.9%
price change
1mo
down 13.1%
price change
12-month return
down 12%
market up 11% ·
its own down 17%
F-score
—
— Not assessed
Altman Z″
0.60
Elevated risk
P/E
—
price / earnings
PEG
—
P/E / EPS growth
P/B
33.2×
price / book
Earnings yield
down 5.2%
EBIT / enterprise value
Cheaper than
9%
of the market · expensive
Revenue growth
—
year on year
EPS growth
—
latest quarter
Sales growth
—
latest quarter
ROE
down 164%
return on equity
Free cash margin
—
-$153.5M FCF
D/E
1.37
long-term debt / equity
Net debt / EBITDA
—
Interest cover
Lossoperating loss
Trade setup
ATR%
5.8%
$4.01 a day · 2×ATR $61.12
RS
11 / 99
vs the universe
Trend
0 / 8
trend template
Relative volume
0.5×
vs 50-day average
Up/down volume
1.07
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 0 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Losing money before interest is even paid The company made an operating loss, so interest is not covered at all - the debt is being serviced from cash reserves, asset sales or new borrowing rather than from the business.
- Shareholders diluted The share count rose 29.9% over the year, from 37m to 48m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
Last reported
Aug 13, 2026
Last shock
Jul 15, 2026-18% in one session5.1× volumeon an SEC filing-24% since
Financials
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Operating income | -$9.6M | -$28.4M | -$39.4M | -$66.2M | -$113.3M | -$172.2M |
| Net income | -$9.5M | -$29.6M | -$40.4M | -$63.8M | -$111.8M | -$177.0M |
| Earnings per share | — | -$2.21 | -$2.62 | -$2.69 | -$2.83 | -$3.79 |
| Free cash flow | -$7.2M | -$20.4M | -$36.2M | -$53.9M | -$83.7M | -$153.5M |
| Cash | $11.6M | $84.3M | $24.6M | $30.7M | $22.5M | $165.7M |
| Long-term debt | $0 | $16.0M | $35.8M | $37.6M | $105.1M | $137.5M |
| Shareholders' equity | $11.7M | $68.7M | $133.8M | $139.8M | $115.6M | $100.6M |
| Shares outstanding | 10.30m | 14.92m | 21.67m | 25.51m | 37.14m | 48.24m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 13, 2026 | Quarterly ↗ | Jun 30, 2026 | 44d |
| May 14, 2026 | Quarterly ↗ | Mar 31, 2026 | 44d |
| Mar 26, 2026 | Annual ↗ | Dec 31, 2025 | 85d |
| Nov 13, 2025 | Quarterly ↗ | Sep 30, 2025 | 44d |
| Aug 14, 2025 | Quarterly ↗ | Jun 30, 2025 | 45d |
| May 15, 2025 | Quarterly ↗ | Mar 31, 2025 | 45d |
| Mar 31, 2025 | Annual ↗ | Dec 31, 2024 | 90d |
| Nov 14, 2024 | Quarterly ↗ | Sep 30, 2024 | 45d |
| Aug 14, 2024 | Quarterly ↗ | Jun 30, 2024 | 45d |
| May 15, 2024 | Quarterly ↗ | Mar 31, 2024 | 45d |
| Mar 27, 2024 | Annual ↗ | Dec 31, 2023 | 87d |
| Nov 13, 2023 | Quarterly ↗ | Sep 30, 2023 | 44d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 2, 2026 | Director or officer change · Regulation FD ↗ |
| Sep 30, 2026 | Regulation FD · Other events ↗ |
| Aug 26, 2026 | Regulation FD · Other events ↗ |
| Aug 13, 2026 | Results ↗ |
| Jul 15, 2026 | Regulation FD · Other events ↗ |
| Jun 8, 2026 | Material agreement · Agreement ended · New obligation · Other events ↗ |
| Jun 2, 2026 | Regulation FD · Other events ↗ |
| May 18, 2026 | Director or officer change · Shareholder vote ↗ |
| May 14, 2026 | Results ↗ |
| May 1, 2026 | Regulation FD · Other events ↗ |
| Mar 25, 2026 | Results ↗ |
| Feb 12, 2026 | Director or officer change · Regulation FD ↗ |